Navigation Links
GERO's Wearable 2.0 Platform to Improve Performance of Activity Trackers
Date:1/8/2014

Las Vegas, NV (PRWEB) January 08, 2014

GERO Corporation today announced the launch of a collaborative effort within the Human Locomotome project to gather and analyze the data of 50,000 Fitbit, Jawbone, and Nike Fuelband users to advance early detection of chronic disease. Chronic diseases are the leading source of health care spending in the United States.

"Locomotor activity, measured by wearable accelerometers, has recently emerged as the single source of an unprecedented volume of continuous high-resolution data characterizing the day-to-day, around-the-clock physiological conditions of millions of people," said Vera Kozyr, co-founder of GERO. "We launched the Human Locomotome project together with our scientists to develop technology for early stage diagnostics by analyzing movement activity. We hope to make the information stable, reliable and accessible."

GERO Lab is a proprietary "crowd-research" wearable 2.0 platform used to collect data and involve people and partners in the study. Ultimately, the GERO Lab platform could help existing activity trackers improve product compliance.

GERO Lab will be able to take advantage of the expected growth in the wearable fitness devices market, expected to reach 90 million units globally by 2017, and another 80 million health-related ones, according to leading research firm ABI (Source: February 2012).

GERO recently conducted a study with 3000 Fitbit users, which confirmed the great potential for the GERO platform. Key takeaways of this study include:
Motor activity contains signatures of particular chronic deceases (metabolic, psychiatric, psychological).
Low-resolution trackers (e.g. Fitbit, Jawbone, etc) can also be used with GERO's mathematical model with sufficient tracking time.
GERO already detects particular health conditions with accuracy.

People who want to contribute their data to the 50K research study may sign up at http://getgero.com

Some of the chronic diseases that can be detected through locomotor activity include diabetes, hypertension, Alzheimer’s and depression. The company hopes its information will make possibly earlier interventions with an eye toward prevention.

About GERO

Moscow-based GERO was founded to develop a new technology platform using mathematical models to identify potential risks for age-related diseases through analysis of everyday movement. Data is being gathered from existing motion trackers, and as the technology evolves, users will have access to its analysis of their personal data, discovering early indicators of specific metabolic, psychiatric and neurological conditions. Armed with this knowledge, people can make health and lifestyle choices to preserve quality of life.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11463292.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring
2. Global Wearable Medical Technology Market 2012 - 2016 : Worldwide Industry Latest Market Share, Growth, Size,Trends , Strategy And Forecast Research Report 2016
3. Phronetic Technologies Announces First Prenatal Smart Wearable Technology; StimElation is Poised for Production
4. Wearable Electronics Market to Reach $8.36 Billion by 2018 at a CAGR of 17.7% - New Report by MarketsandMarkets
5. Wearable Electronics & Smart Textiles Technology Expert Interview - New Announcement by MarketsandMarkets
6. Wearable artificial lung to be developed at Pitt through $3.4 million grant
7. Klingg, the Wearable Magnetic Earphone Cord Holder is Released by Mokao Design
8. Wearable cameras provide new insight into lifestyle behaviors and health
9. 2014 Mint Green Bridesmaid Dresses From Good Platform iFitDress.com
10. RURO Announces a New Version of its LIMS platform Limfinity™ - Version 4.2
11. USAFact’s New RapidFACT Screening Platform Will Launch with Multiple Website Facelifts Tied to Both Old and New Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international ... travel, spa and beauty in Europe. The organization asked its partner experts in Europe ... researchers - to forecast where wellness is headed in Europe. Predictions range from European ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... The Orthopaedic ... executive committee members: , David G. Lewallen, MD, began his term as president ... president. Michael L. Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, will ...
(Date:5/31/2016)... , ... May 31, 2016 , ... In a recent ... Feiner and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical ... what she calls the country’s “modern medical money maelstrom.” , During the interview ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet a growing demand ... industry, The University of Scranton is adding a Certificate in Health Informatics to ... in rapidly growing field of healthcare information. , Healthcare organizations are under ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... use inside of FCPX," said Christina Austin - CEO of Pixel Film Studios. ... use within Final Cut Pro X. Choose from abstract transitions to more simple ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology: